Atosiban and nifedipine in acute tocolysis: A comparative study

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 128, Issue 1-2, 2006, Pages 129-134

  Al Omari, Wafa R ^a   Al Shammaa, Haider B ^a   Al Tikriti, Enas M ^a   Ahmed, Khalid W ^a  

^a BAGHDAD TEACHING HOSPITAL   (Iraq)

Author keywords

Atosiban; Nifedipine; Preterm labor

Indexed keywords

ATOSIBAN; NIFEDIPINE;

ADULT; APNEA; ARTICLE; BRADYCARDIA; BRAIN HEMORRHAGE; CARDIOVASCULAR SYMPTOM; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; FEEDING DISORDER; FEMALE; GASTROINTESTINAL SYMPTOM; HEART ARRHYTHMIA; HEART PALPITATION; HOT FLUSH; HUMAN; HYPERBILIRUBINEMIA; HYPOGLYCEMIA; INDUCED HYPOTENSION; MAJOR CLINICAL STUDY; NAUSEA; NECROTIZING COLITIS; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME; SEPTICEMIA; STATISTICAL SIGNIFICANCE; SYNCOPE; TACHYCARDIA; TACHYPNEA; TREATMENT OUTCOME; VOMITING;

EID: 33748366027     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2005.12.010     Document Type: Article

References (28)

1. Ferguson II J.E., Dyson D.C., Holbrook R.H., et al. Cardiovascular and metabolic effects associated with nifedipine and ritodrine tocolysis. Am J Obstet Gynecol 161 (1989) 788-795
2. Kersie M.J.N.C. New perspectives for the effective treatment of preterm labor. Am J Obstet Gynecol 173 (1995) 618-628
3. Copper R.L., Goldenberg R.L., Greasy R.K., et al. A multicenter study of preterm birth weight and gestational age-specific neonatal mortality. Am J Obstet Gynecol 168 (1993) 78-84
4. Morrison J.C. Preterm birth: a puzzle worth solving. Obstet Gynecol 76 (1990) 85-125
5. Streer P., and Flint C. Preterm labor and premature rupture of membranes. BMJ 318 (1999) 1059-1062
6. Goldenberg R.L., Neslon K.G., Davis R.O., and Koski J. Delay in delivery influence of gestational age and the duration of delay on perinatal outcome. Obstet Gynecol 64 (1984) 480-484
7. Moutquin J.M., Sherman D., Cohen H., et al. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. Am J Obstet Gynecol 182 (2000) 1191-1199
8. Lamont R.F., and Chin B.M. The use of antibiotics in the prevention of preterm birth. In: Studd J. (Ed). Progress in obstetrics and gynecology. 1st ed. vol. 13 (1998), Churchill Livingstone, Edinburgh 141-146
9. Ryank J. Sherris medical microbiology, an introduction to infectious diseases. 3rd ed. (1994), Norwalk, Appleton and Lange p. 775
10. Goodwin T.M., Valenzuela G.J., Silver H., et al. Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Obstet Gynecol 88 (1996) 331-336
11. Papatsonis D.N.M., Van Geijn H.B., Ader H.J., et al. Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial. Obstet Gynecol 2 (1997) 230-234
12. The Canadian Preterm Labor Investigator Group. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl J Med 327 (1992) 208-212
13. Romero R., Siba B.M., Ramos L.S., et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo controlled trial with tocolytic rescue. Am J Obstet Gynecol 182 (2000) 1173-1183
14. Pircon R.A., Strassner H.T., Kriz D.S., et al. Controlled trial of hydration and bed rest versus bed rest alone in the evaluation of preterm uterine contractions. Am J Obstet Gynecol 161 (1989) 775-779
15. RCOG Guidelines No. 1 (B) October 2002. Tocolytic drugs for women in preterm labour.
16. Worldwide Atosiban versus Beta-agonists Study Group. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. BJOG 108 (2001) 133-142
17. French/Australian Atosiban Investigators Groups. Treatment of preterm labor with oxytocin antagonist atosiban: a double-blind randomized controlled comparison with salbutamol. Eur J Obstet Gynecol Reprod Biol 98 (2001) 177-185
18. Valenzuela G.J., Ramos L.S., Romero R., et al. Maintenance treatment of preterm labor with oxytocin antagonist atosiban. Am J Obstet Gynecol 182 (2000) 1184-1190
19. Carr D.B. Maintenance of oral nifedipine for preterm labor: a randomized clinical trial. Am J Obstet Gynecol 181 (1999) 822-827
20. Kirschbaum T. Antibiotics in the treatment of preterm labor. Am J Obstet Gynecol 168 (1993) 1239-1246
21. Goodwin T.M., Valenzuela G.J., Silver H., et al. Treatment of preterm labor with oxytocin antagonist atosiban. Am J Perinatol 13 (1996) 2878-2881
22. Ulmsten U., Andersson K.E., and Wingerup L. Treatment of premature labor with calcium antagonist nifedipine. Arch Gynecol 229 (1980) 1-5
23. Valenzuela G.J., Graig J., Bernhardt M.D., et al. Placental passage of the oxytocin antagonist atosiban. Am J Obstet Gynecol 172 (1995) 1304-1306
24. Ferguson II J.E., Schutz T., Pershe R., et al. Nifedipine pharmatokinetics during preterm labor tocolysis. Am J Obstet Gynecol 161 (1989) 1485-1490
25. Greenwood RL.T. Hyperglycemic effect of nifedipine. BMJ 283 (1981) 19
26. Abadie E., Gauville C., and Brisson C. Nifedipine and endocrine status in diabetic patients. Br J Clin Pharmacol 18 (1984) 648-650
27. Coomarasamy A., Knox E., Gee H., et al. Effectiveness of nifedipine versus atosiban for tocolysis in preterm labour: a meta analysis with an indirect comparison of randomized trials. BJOG 110 12 (December 2003) 1045-1049
28. Papatsonis D.N.M., Kok J.H., Gein V., et al. Neonatal effects of nifedipine and ritodrine for preterm labor. Obstet Gynecol 95 (2000) 477-481